Attached files
| file | filename |
|---|---|
| 8-K - PROGENICS FORM 8-K MARCH 16, 2012 - PROGENICS PHARMACEUTICALS INC | form8_kmarch162012.htm |
EXHIBIT 16.1
March 16, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Progenics Pharmaceuticals, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Progenics Pharmaceuticals, Inc. dated March 16, 2012. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ PricewaterhouseCoopers LLP